Palliative chemotherapy beyond three courses conveys no survival or consistent quality-of-life benefits in advanced non-small-cell lung cancer

por von Plessen, C, Bergman, B, Andresen, O, Bremnes, R M, Sundstrom, S, Gilleryd, M, Stephens, R, Vilsvik, J, Aasebo, U, Sorenson, S
Publicado 2006